Joseph Segelman Insider Profile
4 Followers
Joseph Segelman, CEO, Director, Ten Percent Owner at Sigyn Therapeutics, holds 25.00M shares in Sigyn Therapeutics (Ticker: SIGY). Most recently, Joseph Segelman Bought 2,500 shares of Sigyn Therapeutics on Mar 29, 2017 for an estimated value of $300.00.
Joseph Segelman's Trading History
| SIGYSigyn Therapeutics | Mar 29, 2017 | CEO, Director, Ten Percent Owner | Informative Buy | 300.00 | $675.13K | |
You May Also Like
Joseph Segelman insider profile FAQ
What is the percentage of profitable transactions made by Joseph Segelman?
The percentage of profitable transactions made by Joseph Segelman is 67%.
What is the average return per transaction made by Joseph Segelman?
The average return per transaction made by Joseph Segelman is 23.20%.
What stocks does Joseph Segelman hold?
Joseph Segelman holds: SIGY stocks.
What was Joseph Segelman’s latest transaction?
Joseph Segelman’s latest transaction was an Informative Buy of $300.00.
What was Joseph Segelman's most profitable transaction?
Joseph Segelman’s most profitable transaction was an Informative Buy of SIGY stock on December 15, 2016. The return on the trade was 53.30%.
What is Joseph Segelman's role in Sigyn Therapeutics?
Joseph Segelman's role in Sigyn Therapeutics is CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
